| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10969624 | Vaccine | 2012 | 8 Pages |
Abstract
⺠First time therapeutic vaccine IC41 in treatment naive CHC patients. ⺠Significant HCV viral load decline more pronounced in high viral load patients. ⺠Enhanced effect of IC41 with toll like receptor 7 agonist.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Christoph S. Klade, Elisabeth Schuller, Thomas Boehm, Alexander von Gabain, Michael P. Manns,